xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence 
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute 
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide 
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes 
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit 
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates 
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks 
How Marco Pharma International Preserves German Homeopathic Traditions in America 
ANZ Shares Hit Record High After Strong Q1 Profit and Cost-Cutting Gains 
Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy 
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks 
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act 
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week 
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss 
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims 
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year 
FARMINGTON, CT, Jan. 03, 2018 -- Azitra Inc. today announced that Richard Andrews, President and Chief Executive Officer, is scheduled to present at Biotech Showcase™ 2018 taking place on January 8-10, 2018 at the Hilton San Francisco Union Square, San Francisco, CA. Azitra is focused on treating skin disease by combining the potential of the microbiome with state of the art molecular genetics.
Details for the presentation are as follows:
Date: January 8, 2018
Time: 10:00 am PST
Room: Hilton/Franciscan C, Ballroom Level
Venue: Hilton San Francisco Union Square Hotel, 333 O’Farrell Street, San Francisco, CA
A webcast will be archived shortly after the live event and will be available through the Azitra website at https://azitrainc.com/events/.
About Azitra
Azitra, Inc. is a preclinical stage biotechnology company harnessing the power of the microbiome to treat skin disease. The Company was founded in 2014 by scientists from Yale University and works with world-leading scientists in dermatology, microbiology, and genetic engineering to advance its programs in atopic dermatitis and targeted orphan indications. For more information visit www.azitrainc.com.
Michelle Linn 774-696-3803 [email protected]
